O objetivo da presente Scoping review foi investigar as possibilidades clínicas atuais e futuras das terapias regenerativas e sua capacidade de regenerar tecido ósseo, periodontal e polpar em humanos com confirmação histológica da natureza do tecido formado. Uma busca eletrônica foi realizada utilizando uma combinação entre as palavras-chave e termos MeSH nos bancos de dados PubMed, Scopus, ISI-web of Science e Cochrane library até janeiro de 2016. Dois revisores realizaram de forma independente o julgamento dos documentos. Os estudos selecionados foram lidos seguindo os critérios de inclusão predeterminados. Os estudos incluídos foram avaliados de acordo com a estrutura modificada de Arksey e O‘Malley. Dos 1349 artigos, 168 preencheram os critérios de inclusão. Várias células caracterizadas e não caracterizadas promoveram regeneração óssea utilizada em terapias celulares, demonstrando ganho ósseo em quantidade e qualidade, de forma rápida para regeneração óssea e periodontal. Os scaffolds sintéticos e naturais apresentaram boa manutenção celular, no entanto o poliglicol-polilácido apresentou uma reabsorção rápida e, consequentemente, pequeno ganho ósseo. A terapia mediada por fatores de crescimento foi capaz de regenerar tecido ósseo e todas as características de um tecido periodontal. Dentes submetidos à revascularização apresentaram aumento do comprimento e largura do canal radicular. No entanto, os tecidos formados não foram capazes de depositar dentina, caracterizando um tecido reparado. Tanto o PRP quanto o PRF parecem apresentar benefícios quando aplicados em terapias regenerativas sendo um bom scaffold natural. Portanto, a maioria dos estudos que aplicaram terapias regenerativas forneceram resultados promissores sendo possível regenerar tecido ósseo e periodontal com confirmação histológica. No entanto, não foi observada regeneração de polpa dental. Estes resultados devem ser interpretados com cautela.
Review Article • Braz. Dent. J. 30
(2)
• Mar-Apr 2019 • https://doi.org/10.1590/0103-6440201902053 linkcopiar
Bone, Periodontal and Dental Pulp Regeneration in Dentistry: A Systematic Scoping Review
Autoria
person Luiz Alexandre Chisini
schoolGraduate Program in Dentistry, School of Dentistry, UFPel - Universidade Federal de Pelotas, RS, BrazilUniversidade Federal de PelotasBrazilRS, BrazilGraduate Program in Dentistry, School of Dentistry, UFPel - Universidade Federal de Pelotas, RS, BrazilschoolGraduate Program in Dentistry, School of Dentistry, UNIVATES - Universidade do Vale do Taquari, Lajeado, RS, BrazilUniversidade do Vale do TaquariBrazilLajeado, RS, BrazilGraduate Program in Dentistry, School of Dentistry, UNIVATES - Universidade do Vale do Taquari, Lajeado, RS, Brazil
person Marcus Cristian Muniz Conde
person Guillermo Grazioli
person Alissa Schmidt San Martin
person Rodrigo Varella de Carvalho
person Letícia Regina Morello Sartori
person Flávio Fernando Demarco
Correspondence: Flávio Fernando Demarco, Rua Gonçalves Chaves, 457, 96015-560 Pelotas, RS, Brasil. Tel: +55-53-98111-2528. e-mail: ffdemarco@gmail.com
SCIMAGO INSTITUTIONS RANKINGS
Graduate Program in Dentistry, School of Dentistry, UFPel - Universidade Federal de Pelotas, RS, BrazilUniversidade Federal de PelotasBrazilRS, BrazilGraduate Program in Dentistry, School of Dentistry, UFPel - Universidade Federal de Pelotas, RS, Brazil
Figuras | Tabelas
imageFig.1 PrismaFlowchart open_in_new

imageFigure 2 Studies included in the systematic scoping review according to year of publication open_in_new

imageFigure 3 Pooling of main results open_in_new

imageFigure 4 Main scaffolds reported in the included studies by origin classification. open_in_new

table_chartTable 2
Studies applying SC-BT for bone regeneration
| Year | Author | Cell | Scaffold | Growth Factor | Patients | Follow-up | Parameters | Outcome |
|---|---|---|---|---|---|---|---|---|
| 2003 | Schmelzeisen et al. 65 | Periosteal | Polymer fleece | 2 | 4 months | Histologic and clinical | Mineralized tissue formed | |
| 2004 | Warnke et al. 77 | BMAC | BioOss | rhBMP7 | 1 | Clinical and radiographic | Mineralized tissue formed | |
| 2005 | Ueda et al. 39 | BMMSC | PRP-b-TCP injectable | 6 | 12 months | Radiographic | Mineralized tissue formed (7.3 ± 4.6 mm) | |
| 2007 | Cerruti et al. 75 | MNC | PRP and Bone scaffod | 32 | 8 months | CT, histologic and clinical | Mineralized tissue formed | |
| 2007 | Soltan et al. 78 | BMAC | Allograft bone block | 5 | 8 months | Histologic and histomorphometry | Mineralized tissue formed (54%) | |
| 2007 | Smiler et al. 79 | BMAC | PepGen Putty or C-Graft | 5 | 7 months | Clinical and histologic | Mineralized tissue formed; (45%) | |
| 2007 | Zizelmann et al. 71 | Osteoblast | PLGA | 10 | 3 months | CT | Mineralized tissue formed; High resorption of scaffolds | |
| 2008 | Pradel et al. 72 | Osteoblast | Demineralized bovine bone matrix or from solvent-dehydrated mineralized bovine bone; and graft | 6 | 1 year | Histologic | Mineralized tissue formed. Inflammation and some scaffold resorption was found in 5 months | |
| 2008 | Shayesteh et al. 40 | BMMSC | b-TCP/hydroxyapatite | 6 | 12 months | Clinical, radiographic and histologic | Mineralized tissue formed (41.3%) | |
| 2008 | Yamada et al. 41 | BMMSC | PRP Injectable | 12 | 2-6.3 years: 6.3/ 6.3/ 5.3/ 4.9/ 4.3/ 4.3/ 3.3/ 3.5/ 3.0/ 3.3/ 2.1/ 2.1/ 3.8/ 2.5/ 2.5/ 2.0 | Orthopantomograms, histologic, CT | Mineralized tissue formed; increases of 8.8 ± 1.6 mm | |
| 2009 | Behnia et al. 62 | MSC | Demineralized bone mineral and calcium sulfate (Osteoset) | 2 | 4 months | CT | Mineralized tissue formed (34.5%) | |
| 2009 | D’Aquino et al. 58 | DPSC | Collagen sponge | 7 | 3 months | Histologic and radiographic | Mineralized tissue formed | |
| 2009 | Mangano et al. 73 | Osteoblasts | PLGA | 5 | 6 months | Clinical, histologic and CT | Mineralized tissue formed; fast resorption of scaffold | |
| 2009 | McAllister et al. 70 | MSC and osteoprogenitor cells | Bone graft | 5 | 4.1 months | Clinical, radiographic and histologic | Mineralized tissue formed; (vital bone content of 33% - 22% to 40%-) | |
| 2010 | Lee et al. 42 | BMMSC | Freeze-dried autobone tray and fibrin glue | 1 | 7 months | Histological, clinical and radiographic | Mineralized tissue formed | |
| 2010 | Sauerbier et al. 43 | BMMSC | FICOLL | 4 | 4,1 months; clinical 2 years | Histologic and clinical | Mineralized tissue formed (19.9% Confidence interval 945% 10.9 to 29%) | |
| 2010 | Soltan et al. 80 | BMMAC | Resorbable hydroxylapatite OR Allograft | 2 | 4-6 months | Histologic and radiographic | Mineralized tissue formed (34% to 45%) | |
| 2010 | Mangano et al. 69 | Osteoblasts | PLGA | 1 | 6 months | Histologic and CT | Mineralized tissue formed (28.89% bone and 71.11% medullary spaces) | |
| 2011 | Brunelli et al. 59 | DPSC | Collagen sponge | 1 | 4 months | Clinical, radiographic and histologic | Mineralized tissue formed | |
| 2011 | Graziano et al. 36 | DPSC | Collagen sponge | 1 | 6 months | Clinical and radiographic | Mineralized tissue formed | |
| 2011 | Montesani et al. 68 | osteoblast and periosteal cells | nonwoven polyglactin-910 fibers connected by poly-p-dioxanon bonding | 2 | 12 months | Clinical and radiographic | Mineralized tissue formed | |
| 2011 | Rickert et al. 49 | BMMSC | BioOsss and autogenous stem cells (Test); BioOsss mixed with autogenous bone (Control) | 12 | 14.8 weeks 3-4 months | Histologic | Mineralized tissue formed; test group presented more bone formation than control | |
| 2011 | Sauerbier et al. 81 | BMAS | Autogenous bone combination with a bovine bone mineral | 26 | biopsies 3-4 month | Histologic | Mineralized tissue formed (12.6% ± 1.7%) | |
| 2011 | Schmelzeisen et al. 82 | BMAC | FICOLL | 1 | 3 months | Histologic | Mineralized tissue formed (26.9%); no signs of inflammation | |
| 2012 | Behnia et al. 63 | MSC | Synthetic biphasic bone substitute | PDGF | 3 | 3 months | CT | Mineralized tissue formed (51.3%) |
| 2012 | Hernández-Alfaro et al. 83 | BMAC | Bovine HA | rhBMP-7 | 1 | 1 year | Histologic, clinical and radiographic | Mineralized tissue formed |
| 2012 | Soltan et al. 74 | Concentrated of monocytes | Demineralized allograft material | 2 | 1 year | Radiographic and histologic | Mineralized tissue formed | |
| 2012 | Nagata et al. 67 | Periosteal | Autogenous bone and PRP | 25 | 1 year | CT | Mineralized tissue formed | |
| 2013 | Giuliani et al. 6 | DPSC | Collagen sponge | 7 | 3 years | Histologic and radiographic | Mineralized tissue formed | |
| 2013 | Kaigler et al. 44 | BMMSC | Absorbable gelatin sponge | N=12 Control=12 | 1 year | Clinical, radiographic, CT and histologic | Mineralized tissue formed; therapy accelerated alveolar bone regeneration | |
| 2013 | Sandor et al. 57 | ASC | b-TCP | rhBMP-2 | 1 | 10 months | Histological | Mineralized tissue formed |
| 2013 | Yamada et al. 46 | BMMSC | Membran + PRP Injetável | 1 | 24 months | Histological, CT and radiographic | Mineralized tissue formed | |
| 2013 | Yamada et al. 45 | BMMSC | PRP Injectable | 3 months | Clinical | Mineralized tissue formed.; all patients improved bone tissue | ||
| 2013 | Zamiri et al. 47 | BMMSC | Bone Human cadavers (allograft) | 3 | 6 months | CT | Mineralized tissue formed | |
| 2014 | Marx et al. 84 | BMAC | Collagen sponge | rhBMP-2 | 40 | 6 months | Clinical, CT, radiographic and histologic | Mineralized tissue formed; Patients that received cells presented more bone formation |
| 2014 | Rajan et al. 48 | BMMSC | b-TCP | 1 | biopsy 4 months; and 6 months follow-up | CT and histologic | Mineralized tissue formed; 80% of the original jawbone | |
| 2014 | Rickert et al. 50 | BMMSC | BioOss + MSCs and BioOss + autogenous bone | 12 | 1 year | Clinical and radiographic | Mineralized tissue formed; 3 implant (91%) failed in osteointegration | |
| 2014 | Wildburger et al. 51 | BMMSC | Bio-Oss | 7 | 3 and 6 months | Histological and CT | Mineralized tissue formed (13.5%) | |
| 2015 | Bertolai et al. 52 | BMMSC | PRP and corticocancellous freeze-dried bone chips | 20 | 3 months | Histological and clinical | Mineralized tissue formed | |
| 2015 | Park et al. 53 | BMMSC | Bone from the iliac crest; collagenous membrane | 1 | 1 year | Clinical and radiographic | Mineralized tissue formed | |
| 2015 | Kaigler et al. 54 | BMMSC | b-TCP | Test=13; Control=13 | 1 year | Clinical, radiographic, and histologic | Mineralized tissue formed (12.2% ±3.3) | |
| 2015 | Pasquali et al. 85 | BMAC | Bio-Oss | 8 | 6 months | Histologic | Mineralized tissue formed (55.15 ± 20.91) |
-
beta-tricalcium phosphate (bb-TCP); polyglycolid-polylactid (PLGA); Synthetic polysaccharide (FICOLL); bovine bone mineral (BioOsss); hydroxyapatite (HA); Bone Morphogenetic Protein (rhBMP); Platelet Derived Growth Factor (PDGF); Computed Tomography (CT); Bone Marrow Mesenchymal Stem Cells (BMMSC); Bone Marrow Aspirate Concentrates (BMAC); Adipose stem cells (ASC); Dental Pulp Stem Cells (DPSC); Periodontal Ligament Stem Cells (PDLSC); Mesenchymal Stem Cells (MSC); Mononuclear Cells (MNC); Platelet-Rich Plasma (PRP); Platelet-Rich fibrin (PRF)
table_chartTable 3
Studies applying SC-BT for periodontal regeneration
| Year | Author | Cells | Scaffold | Growth factor | Patients | Follow-up | Parameters | Outcome |
|---|---|---|---|---|---|---|---|---|
| 2006 | Yamada et al. 55 | BMMSC | PRP Injectable | - | 1 | 1 year | Clinical and Radiographic | Bone defects reduced; Reduction on probing depths and gain on clinical attachment |
| 2009 | Okuda et al. 66 | Periosteal | PRP with HA granules | - | 3 | 6 months | Clinical and Radiographic | Radiographic deposition of bone, clinical attachment gain |
| 2010 | Feng et al. 60 | PDLP | Bone Grafting material Calcitite | - | 3 | 32-72 month | Clinical | Decrease in tooth movement and probing depth and attachment gain |
| 2011 | McAllister et al. 56 | MMSC and osteoblast | Allograft bone matrix from cadavers | - | 2 | 6 months | Clinical and radiographic | Radiographic bone deposition and decrease of probing depth |
| 2013 | Sankaranar et al. 76 | MNC | Thermo-reversible gelation polymer | - | 1 | 36 months | Clinical and Radiographic | Bone height was observed radiographically. Reduction of probing pocket depth, improve of clinical attachment |
| 2014 | Aimetti et al. 12 | DPSC | Collagen sponge | - | 1 | 1 year | Clinical and radiographic | Bone increase was observed by radiographic |
| 2015 | Yamada et al. 64 | MSC | PRP and Hyaluronic Acid | - | 1 | Clinical | Volume of papilla increase |
-
beta-tricalcium phosphate (b-TCP); polyglycolid-polylactid (PLGA); Synthetic polysaccharide (FICOLL); bovine bone mineral (BioOsss); hydroxyapatite (HA); Bone Morphogenetic Protein (rhBMP); Platelet Derived Growth Factor (PDGF); Computed Tomography (CT); Bone Marrow Mesenchymal Stem Cells (BMMSC); Bone Marrow Aspirate Concentrates (BMAC); Adipose stem cells (ASC); Dental Pulp Stem Cells (DPSC); Periodontal Ligament Stem Cells (PDLSC); Mesenchymal Stem Cells (MSC); Mononuclear Cells (MNC); Platelet-Rich Plasma (PRP); Platelet-Rich fibrin (PRF).
table_chartTable 4
Studies applying growth factor-mediated therapy
| Year | Author | Scaffold | Growth Factor | Patients | Follow-up | Parameters | Outcome |
|---|---|---|---|---|---|---|---|
| 2003 | Nevins et al. 86 | Demineralized freeze-dried bone allograft | rhPDGF-BB | 9 | 9 mths | Clinical, radiographic and histologic | Probing depth reduction (6.42 mm), clinical attachment level gain 6.17 mm, radiographic fill 2.14 mm; Histological evaluation show periodontal regeneration |
| 2005 | Nevins et al. 87 | b-TCP | rhPDGF-BB | 180 | 6 mths | Clinical and radiographic | Improve bone fill, clinical attachment level and reduce gingival retraction |
| 2006 | McGuire et al. 92 | b-TCP and collagen membrane | rhPDGF | 7 | 6 mths | Clinical | Favorable clinical results in all cases |
| 2009 | Mcguire et al. 93 | b-TCP with a bioabsorbable collagen | rhPDGF-BB | 30 | 6 mths | Clinical, radiographic and Histologic | Recession depth reduction (-2.9 mm), root coverage (90.8%), recession width reduction. Regeneration of periodontal regeneration, cementum and bone. |
| 2009 | Schuckert et al. 94 | Polycaprolactone and PRP | rhBMP-2 | 1 | 6 mths | Radiographic and histologic | Radiographic evidence of bone confirmed by biopsy |
| 2010 | Schuckert et al. 95 | b-TCP and PRP | rhBMP-2 | 1 | 1 yr | CT and histologic | |
| 2011 | Jayakumar et al. 88 | b-TCP | rhPDGFBB | 54 | 6 mths | Clinical, radiographic | Bone gain radiographic, clinical attachment gain and reduction on probing depth |
| 2011 | Nevins et al. 89 | b-TCP | rhPDGF-BB | 3 | 5 mths | Clinical, radiographic and histologic | Bone gain radiograph and histologic |
| 2011 | Nevins et al. 90 | Mineral collagen bone substitute | rhPDGF-BB | 16 | 5 mths | Clinical, radiographic and Histologic | Histological bone; histomorphometric shown more new bone with growth-factor |
| 2011 | Sohn et al. 97 | Fibrin-rich blocks | PRGF | 53 | 10 mths | Clinical, radiographic and Histologic | Histological evidence of bone regeneration |
| 2012 | Anitua et al. 98 | Bovine anorganic bone | PRGF | 5 | 5 mths | Clinical, radiographic and histologic | More vital bone was observed in growth factor group (21.4%) than control (8.4%) even less inflammation. Immunohistochemical show blood vessels |
| 2012 | Taschieri et al. 99 | Deproteinized bovine bone matrix | PRGF | 8 | 6 mths | Clinical and radiographic | Less complication were observed in group treated with PRGF |
| 2013 | Desai et al. 96 | b-TCP | rhBMP-2 | 6 | 12/ 39/ 36/ 50/ 51/ 28 mths | Clinical and radiographic | From 6 patient one develop infection requiring new intervention |
| 2013 | Jensen et al. 91 | Absorbable collagen sponge OR bone autograft/xenograft | rhBMP-2 OR PDGF-bb | 4 | 3 yrs/ 4 mths/ 4 mths/ 6 mths | Clinical and radiographic | Bone gain major than 13 mm in all patients |
| 2013 | Marx et al. 13 | Collagen sponge; cancellous freeze-dried allogeneic bone; PRP | rhBMP-2 | 20 | 6 mths | Clinical, radiographic and histologic | Bone formation (54%) and histological bone regeneration |
| 2013 | Nevins et al. 37 | b-TCP | PDGF-BB | 83 | 36 mths | Clinical and radiographic | Long-term stable clinical and radiographic improvements; |
| 2013 | Sclar et al. 14 | Collagen sponge, autogenous bone graft, bovine bone mineral, PRP, and guided bone regeneration | rhBMP-2 | 1 | 1 yr | Clinical, radiographic and CT | Increase in bone deposition |
| 2014 | Maroo et al. 15 | b-TCP | rhPDGF | 1 | 9 mths | Clinical and radiographic | Pocket defect was totally filled by mineral tissue |
| 2014 | Maroo et al. 16 | b-TCP | rhPDGF-BB | 15 | 9 mths | Clinical and radiographic | Pocket depth reduction, clinical attachment gain, alveolar crest gain |
-
beta-tricalcium phosphate (b-TCP); polyglycolid-polylactid (PLGA); Synthetic polysaccharide (FICOLL); bovine bone mineral (BioOsss); hydroxyapatite (HA); Bone Morphogenetic Protein (rhBMP); Platelet Derived Growth Factor (PDGF); Computed Tomography (CT); Bone Marrow Mesenchymal Stem Cells (BMMSC); Bone Marrow Aspirate Concentrates (BMAC); Adipose stem cells (ASC); Dental Pulp Stem Cells (DPSC); Periodontal Ligament Stem Cells (PDLSC); Mesenchymal Stem Cells (MSC); Mononuclear Cells (MNC); Platelet-Rich Plasma (PRP); Platelet-Rich fibrin (PRF)
table_chartTable 5
Clinical trials applying PRP and PRF for bone pulp and periodontal regeneration
| Year | Author | PRP/PRF | Regeneration | Scaffold /intervention | Control | Patients | Follow-up | Parameters | Outcome |
|---|---|---|---|---|---|---|---|---|---|
| 2004 | Hanna et al. 176 | PRP | Periodontal | Bovine derived xenograft | Bone graft | 30 | 6 mths | Clinical and radiographic | PRP improve the results: CAL and PD |
| 2005 | Okuda et al. 177 | PRP | Periodontal | HA | HA | 35 | 12 mths | Clinical and radiographic | Group with PRP show better results |
| 2008 | Keceli et al. 195 | PRP | Periodontal | Connective tissue graft | Connective tissue graft | 40 | 12 mths | Clinical | No differences with addiction of PRP |
| 2008 | Piemontese et al. 178 | PRP | Periodontal | Demineralized freeze-dried bone allograft | Demineralized freeze-dried bone allograft | 30 | 12 mths | Clinical and radiographic | Greater changes in PD reduction and CAL |
| 2009 | Harnack et al. 196 | PRP | Periodontal | b-TCP | b-TCP | 22 | 6 mths | Clinical and radiographic | PRP did not improve the results |
| 2009 | Pradeep et al. 18 | PRP | Periodontal | PRP alone | Open flap debridement | 20 | 6 mths | Clinical and radiographic | PRP improve the results: CAL and PD |
| 2009 | Torres et al. 180 | PRP | Bone | Anorganic bovine bone | Anorganic bovine bone | 87 | 24 mths | Clinical, radiographic and histologic | No differences; graft resorption was similar treatment and control |
| 2009 | Markou et al. 179 | PRP | Periodontal | Demineralized freeze-dried bone allograft | PRP alone | 24 | 6 mths | Clinical and radiographic | PRP not improve significantly the treatment |
| 2010 | Alissa et al. 181 | PRP | Bone | PRP | - | 20 | 3 mths | Clinical and radiographic | PRP show better bone trabecular pattern |
| 2010 | Arenaz-Búa et al. 182 | PRP | Bone | Synthetic calcium HA or autologous bone OR PRP alone OR allogeneic demineralized bone matrix | Anny material or PRP alone | 82 | 6 mths | Clinical and radiographic | Greatest bone formation was observed in PRP + autologous bone |
| 2010 | Badr et al. 197 | PRP | Bone | Bone graft | Bone graft | 22 | 5-6 mths | Clinical | Improve in the results was not observed with use of PRP |
| 2011 | Sharma et al. 184 | PRF | Periodontal | PRF with conventional open-flap debridement | Conventional open-flap debridement alone | 42 | 9 mths | Clinical and radiographic | Highest percentage of bone fill was found in PRF group |
| 2011 | Yilmaz et al. 185 | PRP | Periodontal | PRP | PPP with Bovine-derived xenograft | 20 | 12 mths | Clinical and radiographic | PPP demonstrated similar efficacy to PRP |
| 2011 | Thorat et al. 186 | PRF | Periodontal | PRF | Conventional open flap debridement alone | 40 | 9 mths | Clinical and radiographic | PRF was better in all clinical and radiographic parameters |
| 2012 | Menezes et al. 187 | PRP | Periodontal | Porous HA and PRP | Porous HA | 60 | 4 yrs | Clinical and radiographic | PRP improve the results |
| 2012 | Pradeep et al. 188 | PRP and PRF | Periodontal | PRP or PRF with open-flap debridement or autologous | Open-flap debridement alone | 54 | 9 mths | Clinical and Radiographic | PD and CAL were better in PRF followed by PRP. Bone fill was more observed in PRF group |
| 2013 | Bajaj et al. 189 | PRP and PRF | Periodontal | PRP or PRF with open-flap debridement | Open-flap debridement alone | 42 | 9 mths | Clinical and radiographic | CAL were better in PRF and PRP. No differences were observed among PRP and PRF |
| 2013 | Khairy et al. 198 | PRP | Bone | PRP with autogenous bone | Autogenous bone | 15 | 6 mths | Clinical, radiographic and histologic | PRP group show more bone density |
| 2013 | Hauser et al. 190 | PRF | Bone | PRF or PRF and socket filling | Extraction alone | 23 | 2 mths | Clinical, radiographic and histologic | PRF group shown better results |
| 2014 | Eskan et al. 191 | PRP | Bone | PRP and resorbable polylactide membrane | Resorbable polylactide without PRP | 28 | 4 mths | Clinical, radiographic and histologic | PRP shown more bone gain |
| 2015 | Angelo et al. 192 | PRF | Bone | Biphasic (60% HA/40% b-TCP) or monophasic (100% b-TCP) | Bi or monophasic without PRF | 82 | 8.3 mths | Clinical, radiographic and histologic | PRF shown superior mechanical stability to restored alveolar bone |
| 2015 | Narang et al. 144 | PRP and PRF | Pulp | PRP and PRF revascularization | Blood Clot revascularization | 15 | 18 mths | Clinical and radiographic | PRF was superior that PRP. PRF and PRF were better than control group |
| 2015 | Pradeep et al. 19 | PRF | Bone and Periodontal | PRF OR PRF with Metformin 1% OR Open-flap debridement with PRF plus 1% metformin | Open-flap debridement alone | 120 | 9 mths | Clinical and radiographic | PRF + 1% MF group showed greater improvements in clinical parameters |
| 2015 | Shah et al. 194 | PRF | Periodontal | Open flap debridement and PRF | Open-flap debridement + Demineralized freeze-dried bone allograft | 20 | 6 mths | Clinical and radiographic | Better result observed in PRF group |
| 2015 | Kumar et al. 193 | PRF | Bone | PRF | 31 | 3 mths | Clinical and radiographic | Bone density was more in PRF group |
-
beta-tricalcium phosphate (b-TCP); polyglycolid-polylactid (PLGA); Synthetic polysaccharide (FICOLL); bovine bone mineral (BioOsss); hydroxyapatite (HA); Bone Morphogenetic Protein (rhBMP); Platelet Derived Growth Factor (PDGF); Computed Tomography (CT); Bone Marrow Mesenchymal Stem Cells (BMMSC); Bone Marrow Aspirate Concentrates (BMAC); Adipose stem cells (ASC); Dental Pulp Stem Cells (DPSC); Periodontal Ligament Stem Cells (PDLSC); Mesenchymal Stem Cells (MSC); Mononuclear Cells (MNC); Platelet-Rich Plasma (PRP); Platelet-Rich fibrin (PRF); probing depth (PD), Clinical Attachment Level (CAL)
Como citar
location_on
Fundação Odontológica de Ribeirão Preto
Av. do Café, S/N, 14040-904 Ribeirão Preto SP Brasil, Tel.: (55 16) 3602-3982, Fax: (55 16) 3633-0999 -
Ribeirão Preto -
SP -
Brazil
E-mail: bdj@forp.usp.br
E-mail: bdj@forp.usp.br
rss_feed
Acompañe los números de esta revista en su lector de RSS
Versão para download de PDF
Artículos relacionados
Lista de links para artigos relacionados. Os links abrem em nova aba.
Versões e tradução automática
Escolha a versão original do texto ou utilize um serviço de tradução automática.
Versão original do texto
Como citar
Escolha um formato para exportar ou selecione um estilo de citação. O conteúdo abaixo pode ser atualizado após a seleção.
Thumbnail
Thumbnail
Thumbnail
Thumbnail